TERRY TOO SOON
Dead / Cancelled — Cancelled — Section 8 (as of 03 Apr 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74337955
- Registration number
- 1859068
- Mark type
- Word mark
- Filed
- 08 Dec 1992
- Published for opposition
- 07 Sept 1993
- Registered
- 18 Oct 1994
- Next maintenance due
- 18 Oct 2004
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 016 — Paper goods and printed matter: newsletters, pamphlets and books dealing with precocious puberty
- Class 042 — Scientific and technological services: providing consulting services to parents and children relating to precocious puberty
Owner
- ABBVIE ENDOCRINE INC., NORTH CHICAGO, IL, US
- TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., DEERFIELD,, IL, US
- TAP PHARMACEUTICALS PRODUCTS, INC, Lake Forest, IL, US
- TAP pharmaceuticals Inc., LAKE FOREST, IL, US
- TAP pharmaceuticals Inc., North Chicago, IL, US
- TAP pharmaceuticals Inc., North Chicago, IL, US
Prosecution history
- 03 Apr 2020 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 01 May 2013 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Mar 2013 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2013 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Jan 2012 — REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY NOT ENTERED
- 06 Jan 2012 — PAPER RECEIVED
- 22 Dec 2011 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Feb 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Feb 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2009 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 24 Dec 2008 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Dec 2008 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Jul 2007 — CASE FILE IN TICRS
- 09 Aug 2005 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Aug 2005 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED